Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

Living with Cancer Pain

Investigating the Molecular Mechanisms of Cancer

Microfluidic cancer treatment screen combined with flow cytometry

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

Is Cancer a Metabolic Disorder?

TARDIS: The Improved Method of Detecting Breast Cancer

Insights into Oncofertility

Pediatric Cancer

The Biochemistry of Breast Cancer Screening

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

British Pioneers in Cancer Biology

See more featured articles »

Cancer Pain Management

Metastatic Migration in Cancer may be Influenced by Metabolism

Secondary Lung Cancer

Using Biomarkers to Detect Cancer

Transforming Cancer Care through Genomic Testing

Caring for a Loved One with Cancer

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

Effects of Social and Economic Deprivation on Cancer Mortality

Cancer Glossary

The Cancer Cell Surface Proteome as a Therapeutic Target

What Role do Biobanks Play in Cancer Research?

Extracellular Vesicles as Floating Cancer Biomarkers

What is Cancer?

Cutaneous Manifestations of Internal Malignancy

What is the Tumor Microenvironment?

Cancer Prognosis

What Causes Cancer?

Overview of Cell Viability and Cytotoxicity

Myc Mutations and Cancer

What is Immunochemotherapy?

What is Tumorigenesis?

Cancer Management

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Targeted Cancer Therapies

Cancer Screening Considerations: Balancing the Benefits and Risks

Cancer Epidemiology

Insight into Cancer Vaccines

Cancer Research

Cancer Pathophysiology

What is Merkel Cell Carcinoma?

Hypoxia Markers and Their Importance

Cancer History

Cancer Diagnosis

Exploiting Enzymes in Cancer Diagnosis and Therapy

CDK9 and Cancer

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

Hot vs Cold: the differences between tumor types

Cancer Pain

The Effects of Cancer on Family Life

Secondary Brain Cancer

Why are Cancer Cell Lines Useful?

Assay for Monitoring and Treating Malignant Brain Tumors

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

What is Cancer of Unknown Primary?

Cancer Symptoms

Acidosis and Tumor Progression

Cancer Classification

Cancer Prevention: Lowering your Risk

Latest Cancer News and Research

Tumor splicing burden predicts treatment response in kidney cancer

Researchers at City of Hope® and TGen (part of City of Hope) have identified a significant correlation between a tumor's "splicing burden" and its clinical response to treatment for metastatic renal cell carcinoma (mRCC).

5 May 2026

Hand-held wireless probe helps surgeons identify breast cancer tumors

Breast cancer impacts over 2 million women around the world each year. Following radiotherapy or chemotherapy, breast-conserving surgery is the first line of intervention for early-stage breast cancer.

5 May 2026

AI creates detailed map of fat and muscle distribution to predict major health risks

Researchers used AI to analyze whole-body MRI scans from more than 66,000 participants to create the most detailed reference map to date of how fat and muscle are distributed in the human body across age, sex and height.

5 May 2026

Specific health labels may better motivate reduced alcohol consumption

Although the United States requires a warning label on alcoholic beverages, alcohol-related deaths have risen steadily over the past two decades.

5 May 2026

A new tool that predicts obesity-related disease risk beyond BMI

OBSCORE is a data-driven tool that identifies high-risk individuals for obesity-related diseases, enhancing treatment targeting beyond traditional BMI metrics.

5 May 2026

ASPIRE trial explores survival benefits of adding chemotherapy to standard prostate cancer treatment

The Alliance for Clinical Trials in Oncology is now enrolling patients in the ASPIRE trial (A032302)-a large-scale, phase III clinical study investigating whether adding chemotherapy to current standard treatments extends survival for men with advanced prostate cancer.

4 May 2026

EVALI outbreak reshaped public perceptions of e-cigarette harm

Cigarettes are one of the deadliest products on the market – but the risks of alternatives are not always clearly understood.

4 May 2026

NIH awards $3.9 million grant to develop a non-opioid pain treatment

The National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health (NIH), has awarded a $3.9 million grant to a multi-institutional team led by scientists at Sanford Burnham Prebys Medical Discovery Institute to develop a non-opioid pain therapeutic and advance it into a Phase 1 clinical trial.

4 May 2026

NIH grant fuels NYU Langone efforts to accelerate medical research discoveries

NYU Langone Health has been awarded a nearly $70 million, seven-year renewal grant from the National Institutes of Health (NIH) to fund its Clinical and Translational Science Institute (CTSI). The award is the highest level of funding available nationally under NIH's Clinical and Translational Science Awards (CTSA) Program.

4 May 2026

New technique uses electronic jolt and nanoparticles to reveal early signs of pancreatic cancer

Scientists at Oregon Health & Science University have developed a new technique using an electronic jolt and nanoparticles to reveal the telltale signal of an insidious form of cancer.

4 May 2026

A more accurate tool for assessing Arsenic toxicity

Public health experts estimate that more than 200 million people worldwide are exposed to arsenic through contaminated drinking water. Scientists know long-term exposure to arsenic is associated with increased risk of chronic illnesses like cancer and cardiovascular disease, but there hasn't been a reliable way to track these exposures and fully understand their effects on the body and the mechanisms behind them.

4 May 2026

Five diet patterns shaping health in older Americans

Research identifies distinct dietary patterns in older adults, revealing how nutrition impacts health outcomes and food security among this vulnerable group.

4 May 2026

New genomic study tracks rare blood disease in children

Aplastic anemia is a rare, life-threatening blood disorder where patients are unable to make enough blood cells due to the immune system's attack on blood stem cells. The condition can progress to myelodysplastic syndrome (MDS) and leukemia. A study led by scientists at St. Jude Children's Research Hospital, with multiple collaborating institutions, used state-of-the-art genomic techniques to profile 619 children and adults with aplastic anemia.

4 May 2026

New genetic tool tracks how bacteria spread between people

The research, published on April 24th, 2026, in Nature Microbiology, describes how the new tool, called TRAnsmision Clustering of Strains (TRACS), uses genomics to distinguish between closely related bacterial strains.

4 May 2026

Child health experts launch GenHEART to tackle Australia's obesity crisis

Heart health, diet, exercise and sleep will be targeted under a multi-pronged strategy by child health experts to address Australia's obesity crisis.

4 May 2026

Researchers leverage tamoxifen's active metabolite to improve breast cancer prevention

Low doses of the investigational medicinal product endoxifen reduce breast density to the same extent as the standard treatment tamoxifen, but without causing such troublesome side effects. This is shown by a new study from Karolinska Institutet published in the Journal of the National Cancer Institute. The results may have implications for future preventive treatment of breast cancer.

4 May 2026

65 % of eligible lung cancer patients do not receive the most appropriate targeted therapies, Diaceutics report finds

Diaceutics, the intelligence and engagement company unlocking the full potential of diagnostic-driven therapies, has released new research revealing a critical shift in precision medicine. Despite major advances in biomarker testing, nearly two-thirds of eligible patients with advanced non-small cell lung cancer (aNSCLC) in the US are still not receiving the most appropriate treatment

From Diaceutics PLC 4 May 2026

AAD survey reveals Americans ignore sun risks despite skin cancer concerns

The American Academy of Dermatology (AAD) today released results from its annual Practice Safe Sun Survey, revealing many Americans still engage in risky sun behaviors driven by misinformation, social media, and persistent tanning myths despite their concerns about the long term aging effects of sun exposure. In recognition of Skin Cancer Awareness Month (May) and Melanoma Monday® on May 4, the AAD is encouraging the public to practice safe sun to reduce their risk of skin cancer.

4 May 2026

How fast your face ages may predict cancer survival outcomes

The study links facial aging rates to cancer outcomes, suggesting a new prognostic tool that could personalize treatment and enhance patient survival.

1 May 2026

Food timing may shape how T cells respond to infection and therapy

Short-term nutritional state can reshape T cell metabolism, with post-meal lipid metabolism enhancing T cell metabolic capacity, cytokine production, and persistence after activation. The study identifies triglyceride-rich chylomicrons as key drivers of this effect, suggesting nutritional timing may matter for immune monitoring, vaccination research, and cell-therapy manufacturing.

30 Apr 2026